- Report
- December 2023
- 171 Pages
Global
From €3489EUR$3,633USD£3,004GBP
€4985EUR$5,190USD£4,292GBP
- Report
- November 2023
- 420 Pages
Global
From €3059EUR$3,185USD£2,634GBP
€4370EUR$4,550USD£3,762GBP
- Report
- February 2024
- 184 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- February 2024
- 181 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- February 2024
- 179 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- January 2024
- 188 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- November 2023
- 188 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- October 2023
- 172 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- October 2023
- 190 Pages
Global
From €4706EUR$4,900USD£4,052GBP
- Report
- February 2024
- 150 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- February 2024
- 120 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- February 2024
- 112 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- February 2024
- 110 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Drug Pipelines
- April 2024
- 100 Pages
Global
From €1921EUR$2,000USD£1,654GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1441EUR$1,500USD£1,240GBP
- Drug Pipelines
- April 2024
- 50 Pages
Global
From €1441EUR$1,500USD£1,240GBP
- Drug Pipelines
- April 2024
- 70 Pages
Global
From €1441EUR$1,500USD£1,240GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1201EUR$1,250USD£1,034GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1921EUR$2,000USD£1,654GBP
- Clinical Trials
- April 2024
- 120 Pages
Global
From €1921EUR$2,000USD£1,654GBP
The Antimicrobial Resistance (AMR) market is a subset of the healthcare services industry that focuses on the development of treatments and strategies to combat the growing threat of drug-resistant bacteria. AMR is a major public health concern, as it can lead to increased morbidity and mortality, as well as higher healthcare costs. To address this issue, the market is focused on developing new antibiotics, diagnostics, and vaccines, as well as strategies to reduce the spread of drug-resistant bacteria. Additionally, the market is focused on improving the stewardship of existing antibiotics, as well as developing new strategies to reduce the emergence of drug-resistant bacteria.
Some companies in the AMR market include Merck & Co., Pfizer, GlaxoSmithKline, Sanofi, Johnson & Johnson, Novartis, and AstraZeneca. Show Less Read more